Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Agilent Technologies (A)

Agilent Technologies (A)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 34,440,704
  • Shares Outstanding, K 282,602
  • Annual Sales, $ 6,948 M
  • Annual Income, $ 1,303 M
  • EBIT $ 1,456 M
  • EBITDA $ 1,744 M
  • 60-Month Beta 1.30
  • Price/Sales 4.81
  • Price/Cash Flow 17.83
  • Price/Book 4.84

Options Overview Details

View History
  • Implied Volatility 31.13% (-0.25%)
  • Historical Volatility 23.79%
  • IV Percentile 43%
  • IV Rank 34.66%
  • IV High 43.04% on 05/23/25
  • IV Low 24.82% on 12/30/25
  • Expected Move (DTE 25) 6.63 (5.48%)
  • Put/Call Vol Ratio 0.13
  • Today's Volume 1,974
  • Volume Avg (30-Day) 901
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 17,942
  • Open Int (30-Day) 19,995
  • Expected Range 114.33 to 127.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/26
See More
  • Average Estimate $1.41
  • Number of Estimates 6
  • High Estimate $1.42
  • Low Estimate $1.39
  • Prior Year $1.31
  • Growth Rate Est. (year over year) +7.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
109.90 +10.06%
on 03/27/26
121.93 -0.80%
on 04/17/26
+9.66 (+8.68%)
since 03/20/26
3-Month
109.90 +10.06%
on 03/27/26
141.19 -14.33%
on 01/22/26
-14.87 (-10.95%)
since 01/20/26
52-Week
99.12 +22.03%
on 04/21/25
160.27 -24.53%
on 11/25/25
+18.48 (+18.03%)
since 04/17/25

Most Recent Stories

More News
3 Reasons A is Risky and 1 Stock to Buy Instead

3 Reasons A is Risky and 1 Stock to Buy Instead

A : 120.96 (-0.75%)
Agilent Showcases Cancer Research Solutions at AACR 2026

Agilent Technologies Inc. (NYSE: A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for...

A : 120.96 (-0.75%)
3 S&P 500 Stocks with Warning Signs

3 S&P 500 Stocks with Warning Signs

PCAR : 128.31 (+1.63%)
A : 120.96 (-0.75%)
RVTY : 93.03 (-0.99%)
3 Profitable Stocks We’re Skeptical Of

3 Profitable Stocks We’re Skeptical Of

AR : 36.57 (-0.30%)
A : 120.96 (-0.75%)
ARCB : 119.15 (+0.43%)
Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader

Agilent Technologies, Inc. (NYSE: A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading...

A : 120.96 (-0.75%)
The Often-Missed Corner of Healthcare That Wall Street Is Loving

Makers of crucial lab equipment and materials for the healthcare industry play a vital, though often overlooked, role for some higher-risk companies.

A : 120.96 (-0.75%)
TMO : 526.02 (-0.11%)
DHR : 195.50 (+0.39%)
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma

Test enables identification of patients whose tumors express PD-L1 for potential treatment with KEYTRUDA® (pembrolizumab) 1, 2

A : 120.96 (-0.75%)
Q4 Earnings Outperformers: Agilent (NYSE:A) And The Rest Of The Research Tools & Consumables Stocks

Q4 Earnings Outperformers: Agilent (NYSE:A) And The Rest Of The Research Tools & Consumables Stocks

A : 120.96 (-0.75%)
Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026

Expanded PD‑L1 indication and end‑to‑end digital pathology workflows support modern pathology practice

A : 120.96 (-0.75%)
Is Waters Corporation Stock Underperforming the Dow?

Waters Corporation stock has underperformed the Dow over the past year, but analysts remain moderately bullish about its prospects.

A : 120.96 (-0.75%)
$DOWI : 49,442.56 (-0.01%)
WAT : 335.61 (+2.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments,...

See More

Key Turning Points

3rd Resistance Point 122.69
2nd Resistance Point 122.01
1st Resistance Point 121.48
Last Price 120.96
1st Support Level 120.27
2nd Support Level 119.59
3rd Support Level 119.06

See More

52-Week High 160.27
Fibonacci 61.8% 136.91
Fibonacci 50% 129.70
Fibonacci 38.2% 122.48
Last Price 120.96
52-Week Low 99.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.